2m 2m 2m 2m 2m 2m 2m
Grace Therap (GRCE)
NASDAQ
$2.51+$0.08 (+3.29%)
Price as of Jul 14, 2026 12:33 PM EDT- $39.5MMarket Cap
- -26.59%1-Year Change
- BiotechnologyIndustry
Grace Therap (GRCE)
$2.51+$0.08 (+3.29%)
GRCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.43 | ||
Change | -$0.02 (-0.82%) | ||
Open | $2.50 | ||
High | $2.50 | ||
Low | $2.38 | ||
Previous Close | $2.45 | ||
Volume | 116,772 | ||
30-Day Average Volume | 277,540 | ||
1-Week Change | -3.95% | ||
1-Month Change | 10.45% | ||
1-Year Change | -26.59% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 16.3M | ||
Total Assets | $66.7M | ||
Market Cap | $39.5M | ||
Enterprise Value | $22.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.2M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $15.2M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -36 | ||
PEG | -1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue